Health & bio
AJMC: FDA speeds approvals with single-trial pathway
AJMC reported FDA now permits one clinical trial for some new-drug approvals, speeding time-to-market but raising safety-validation concerns.
Primary sources · 1
AJMC reported FDA now permits one clinical trial for some new-drug approvals, speeding time-to-market but raising safety-validation concerns.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.